Department of Chemical Engineering, The University of Texas, Austin, Texas, USA; email:
Department of Molecular Biosciences, The University of Texas, Austin, Texas, USA.
Annu Rev Chem Biomol Eng. 2023 Jun 8;14:217-241. doi: 10.1146/annurev-chembioeng-101121-084508. Epub 2023 Mar 14.
There is growing interest in identifying antibodies that protect against infectious diseases, especially for high-risk individuals and pathogens for which no vaccine is yet available. However, pathogens that manifest as opportunistic or latent infections express complex arrays of virulence-associated proteins and are adept at avoiding immune responses. Some pathogens have developed strategies to selectively destroy antibodies, whereas others create decoy epitopes that trick the host immune system into generating antibodies that are at best nonprotective and at worst enhance pathogenesis. Antibody engineering strategies can thwart these efforts by accessing conserved neutralizing epitopes, generating Fc domains that resist capture or degradation and even accessing pathogens hidden inside cells. Design of pathogen-resistant antibodies can enhance protection and guide development of vaccine immunogens against these complex pathogens. Here, we discuss general strategies for design of antibodies resistant to specific pathogen defense mechanisms.
人们越来越关注能够预防传染病的抗体,尤其是针对那些高危人群和尚无疫苗可用的病原体。然而,表现为机会性或潜伏性感染的病原体表达出复杂的毒力相关蛋白阵列,并且善于逃避免疫反应。一些病原体已经开发出选择性破坏抗体的策略,而另一些则产生诱饵表位,欺骗宿主免疫系统产生最好是非保护性的,最坏是增强发病机制的抗体。抗体工程策略可以通过访问保守的中和表位、生成抵抗捕获或降解的 Fc 结构域,甚至访问隐藏在细胞内的病原体来挫败这些努力。病原体抗性抗体的设计可以增强保护作用,并指导针对这些复杂病原体的疫苗免疫原的开发。在这里,我们讨论了设计能够抵抗特定病原体防御机制的抗体的一般策略。